What is the recommended management for placenta percreta?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Placenta Percreta

Placenta percreta requires planned cesarean hysterectomy with the placenta left in situ at 34 0/7 to 35 6/7 weeks of gestation, performed by a multidisciplinary team at a Level III or IV maternal care facility with massive transfusion capability. 1

Delivery Location and Team Assembly

Transfer to a Level III or IV maternal care facility is mandatory if not already at one, as outcomes are significantly optimized when delivery occurs at centers experienced with placenta accreta spectrum. 1, 2

The multidisciplinary team must include:

  • Maternal-fetal medicine specialists 1, 2
  • Gynecologic oncology or female pelvic medicine surgeons 2
  • Anesthesiology with massive transfusion experience 3, 2
  • Neonatology 3, 2
  • Blood bank with massive transfusion protocol capability 3, 2
  • Interventional radiology (available but not routinely used) 2

Optimal Timing of Delivery

Schedule cesarean hysterectomy at 34 0/7 to 35 6/7 weeks of gestation in stable patients, as decision analysis demonstrates this window optimally balances neonatal outcomes against maternal hemorrhage risk. 1, 2

Do not delay delivery beyond 36 0/7 weeks, as approximately 50% of women with placenta accreta spectrum beyond 36 weeks require emergent delivery for hemorrhage. 2, 4

Earlier delivery is required for:

  • Persistent bleeding 1
  • Preeclampsia 1
  • Labor or rupture of membranes 1
  • Fetal compromise 1
  • Developing maternal comorbidities 1

Preoperative Optimization

Coordinate with the blood bank for massive transfusion protocol activation, as blood loss can be massive (median 3,000 mL in immediate hysterectomy cases). 2, 5

Optimize hemoglobin preoperatively by:

  • Evaluating and aggressively treating iron deficiency anemia 3, 2
  • Using oral iron replacement 2
  • Considering intravenous iron infusions 3, 2
  • Considering erythropoietin-stimulating agents when indicated 2

Perform thorough preoperative evaluation including airway assessment, hemoglobin levels, and coagulation status. 3

Anesthetic Management

Neuraxial anesthesia (combined spinal-epidural) is preferred as it provides benefits including maternal awareness during delivery. 3

Prepare for massive transfusion with cell salvage technology available when possible. 3

Consider tranexamic acid to reduce blood loss. 3

Surgical Approach: The Gold Standard

The definitive management is planned cesarean hysterectomy with placenta left in situ. 1, 2

Critical Surgical Principles:

Never attempt placental removal, as this causes catastrophic hemorrhage. 2, 4

Deliver the fetus through a uterine incision that avoids the placenta when possible. 2

Ligate the umbilical cord close to the placenta and proceed directly to hysterectomy without attempting placental separation. 2

Have massive transfusion protocol activated and ready before beginning the procedure. 2

For cases with suspected bladder involvement, consider ureteric stent placement and collaboration with urologic surgeons. 4

Intraoperative Hemorrhage Management

If massive bleeding occurs, transfuse in 1:1:1 to 1:2:4 ratio (packed RBCs:FFP:platelets). 1, 3

Administer tranexamic acid to reduce blood loss. 3

Monitor fibrinogen levels closely and maintain maternal temperature >36°C for optimal clotting factor function. 4

Activate massive transfusion protocol early rather than late. 3

Be prepared for vasopressor support as needed. 3

Alternative Management: Delayed Hysterectomy (Selected Cases Only)

While immediate cesarean hysterectomy is the gold standard, delayed hysterectomy 4-6 weeks after delivery may be considered in highly selected cases where intraoperative assessment suggests it is feasible. 5

Evidence shows delayed hysterectomy results in:

  • Significantly lower blood loss (median 750 mL vs 3,000 mL for immediate hysterectomy) 5
  • Lower transfusion requirements (0 units vs 4 units median) 5
  • Fewer patients requiring ≥4 units transfusion (14.2% vs 45%) 5

However, this approach requires:

  • Fetal surgery technique for hysterotomy to minimize blood loss 5
  • Leaving placenta completely in situ 5
  • Close monitoring for complications 5
  • Readiness for emergency hysterectomy if bleeding occurs 5

Conservative/expectant management is investigational and carries significant risks, including 22-42% still requiring hysterectomy, 28% developing infection/febrile morbidity, and 6% experiencing severe morbidity (sepsis, organ failure, death). 1, 2

Postoperative Care

Plan for potential ICU monitoring given risks of ongoing bleeding, fluid overload, and renal failure. 3, 2

Monitor for complications including:

  • Renal failure 3
  • Liver failure 3
  • Infection 3
  • Unrecognized injuries 3
  • Pulmonary edema 3
  • Disseminated intravascular coagulation 3
  • Sheehan syndrome (postpartum pituitary necrosis) in cases with significant hypoperfusion 3

Maintain low threshold for reoperation if ongoing bleeding is suspected. 2

Monitor for delayed complications including infection and thromboembolic events. 2

Critical Pitfalls to Avoid

Never attempt manual placental removal, as this causes catastrophic hemorrhage and is the most common preventable error. 2, 4

Do not delay delivery beyond 36 weeks in a stable patient. 2

Do not deliver at a facility without massive transfusion capability and experienced surgical team. 2

If placenta percreta is encountered unexpectedly at delivery, temporarily pause the case until optimal surgical expertise can be mobilized, assuming maternal and fetal stability allow. 1, 3

If the delivering center lacks expertise and the patient is stable after fetal delivery, transfer to a facility that can perform the necessary level of care. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anesthetic Management for Placenta Percreta

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management and Treatment of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best management approach for a primigravid (first-time pregnant) patient with placenta percreta?
What is the recommended management for a pregnant woman with suspected placenta percreta?
What is the best course of action for a pregnant woman with placenta percreta and vaginal bleeding, currently in a hospital that is not equipped to manage her condition?
What are the key findings and management strategies for a woman of childbearing age with a history of uterine surgery or previous placental abnormalities diagnosed with placenta percreta?
What is the typical placental description in a case of placenta percreta in an adult female with a history of previous uterine surgery or placenta previa?
Can Veozah (fezolinetant) be taken at night in a postmenopausal woman with vasomotor symptoms?
In an adult with obesity (BMI ≥ 30 kg/m²) eligible for chronic weight‑management therapy, how do Zepbound (tirzepatide) and Wegovy (semaglutide) compare in expected weight loss, dosing schedule, adverse‑effect profile, and which should be preferred as first‑line?
What is the appropriate management for a patient with a trough serum valproic acid level of 37 µg/mL who is taking divalproex 250 mg twice daily?
What is the correct dose of famotidine oral suspension (40 mg/5 mL) for an 8‑month‑old infant weighing 5 kg?
How should I evaluate and treat a 10‑to‑19‑year‑old adolescent presenting with foot swelling without any specific history?
How rare is a posterior circulation transient ischemic attack (TIA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.